News on Medial

Health-tech startup Dectrocel raises Rs 4 Cr led by IAN Group-backed BoiAngels

EntrackrEntrackr · 2m ago
Health-tech startup Dectrocel raises Rs 4 Cr led by IAN Group-backed BoiAngels
Medial

Dectrocel, a health-tech startup developing AI-powered diagnostic solutions, has raised Rs 4 crore in a funding round led by IAN Group-powered BioAngels along with participation from PadUp Ventures and Vinners. The proceeds will be used to scale its commercial operations across India, enhance AI technology, expand into international markets, and accelerate the launch of new AI tools in CT/MRI/PET-CT and HPB diagnostic modules. Co-founded in 2020 by Ankit Shukla, Saumya Shukla, and Nikhil Mishra, Dectrocel's flagship product, DecXpert, delivers chest X-ray and CT-scan interpretations, is one of only three AI-based diagnostic tools approved for clinical use in India, and claims it is 10x faster with 98% accuracy. Dectrocel aims to bridge the diagnostic gap caused by a shortage of radiologists in India, particularly in smaller cities, by providing quality diagnostics equivalent to those in metro hospitals. The company plans to expand its commercial deployment across OEM partner networks, penetrate the Rs 1,000 crore digital X-ray market, and establish an initial presence in Southeast Asia.

Related News

Lamark Biotech raises Rs 6.5 Cr in pre-Series A round led by IAN Group

EntrackrEntrackr · 4m ago
Lamark Biotech raises Rs 6.5 Cr in pre-Series A round led by IAN Group
Medial

Lamark Biotech raises Rs 6.5 Cr in pre-Series A round led by IAN Group Lamark's proprietary ProteoStrong platform enables the stabilization of fragile protein-based drugs, such as insulin, monoclonal antibodies, and enzymes, without altering their molecular structure. Biopharma startup Lamark Biotech has raised Rs 6.5 crore in a pre-Series A round led by IAN Group, including IAN Alpha Fund, powered by BioAngels, Vinayender Tulla, Nita Roy, and Venkataraman KNK. Domain experts from IAN’s angel investors led the round. The Ahmedabad-based company had previously raised $41.3K in a seed funding round led by VIT-TBI and others. The fresh funds will be utilized to accelerate the development of thermostable insulin and expand the biologics platform for global access, Lamark said in a press release. Founded in 2018 by Vaibhav Bhatia, Lamark Biotech aims to reimagine drug delivery for chronic and life-altering diseases. Its proprietary ProteoStrong platform enables the stabilization of fragile protein-based drugs, such as insulin, monoclonal antibodies, and enzymes, without altering their molecular structure. According to Lamark Biotech, it leverages the R&D base of Venture Center, NCL Innovation, and it is advancing a new class of temperature-resilient biologics that retain potency across extreme conditions—ideal for underserved regions where cold storage infrastructure is limited. With its lead program, InsulinStrong, Lamark is targeting the Rs 4,000 crore Indian insulin market and intends to expand across Southeast Asia and the UAE. In the next 24 months, it plans to file new international patents, begin early clinical trials, and build partnerships with pharma companies, CDMOs, and global health agencies.

StampMyVisa raises Rs 4 Cr in bridge round led by Unicorn India Ventures

EntrackrEntrackr · 18d ago
StampMyVisa raises Rs 4 Cr in bridge round led by Unicorn India Ventures
Medial

Snippets StampMyVisa raises Rs 4 Cr in bridge round led by Unicorn India Ventures B2B visa processing platform StampMyVisa (SMV) has raised Rs 4 crore in a bridge round led by existing investor Unicorn India Ventures (UIV). The fresh capital will be used for growth, marketing and to support the company’s recent acquisition of Kunal Shah backed Teleport, which expands its operations in South India. Unicorn India Ventures had earlier invested Rs 6.6 crore in StampMyVisa during its seed round last year. The company aims to use this bridge round to achieve key milestones before raising a larger Series A round in the next financial year. StampMyVisa said it has achieved 4 times growth in revenue while maintaining a 99.5% visa success rate, processing more than 75,000 visas in the past six months. Its proprietary AI engine Nucleus automates and validates visa documentation for over 80 countries. The company recently introduced new products including SMV Insure, which refunds the booking value if a visa is rejected, and SMV Global, an eSIM service offering international connectivity at lower cost than regular roaming. It plans to expand into GCC markets and build fintech infrastructure with embedded credit and payment solutions for small and medium businesses. The platform targets to process 80% of visa applications within five minutes, compared to the current industry average of two days. In August 2025, StampMyVisa acquired travel tech startup Teleport, a consumer facing player backed by founders including Kunal Shah, Vidit Aatrey and Phanindra Sama. It competes with Atlys, Visa2Fly and StampThePassport.

EndureAir raises $2.85 Mn led by IAN Alpha Fund

EntrackrEntrackr · 2m ago
EndureAir raises $2.85 Mn led by IAN Alpha Fund
Medial

EndureAir raises $2.85 Mn led by IAN Alpha Fund EndureAir Systems, a deep-tech UAV (Unmanned Aerial Vehicle) and aerial robotics firm, has raised Rs 25 crore (about $2.85 million) in funding led by IAN Alpha Fund, with participation from IAN Angel Fund. The proceeds will be used to strengthen its UAV capabilities for the defense ecosystem, expand into enterprise markets, and accelerate the development of next-generation high-altitude logistics and aerial robotics platforms. Founded in 2018 by Dr. Abhishek along with his former students Rama Krishna and Chirag Jain, EndureAir designs and manufactures rugged, indigenous UAVs for logistics, defense, surveillance, and disaster response. Unlike drone assemblers, the brand develops both hardware and software fully in-house, leveraging over 15 years of rotorcraft research and backed by 8 patents in flight dynamics and autonomy. EndureAir’s UAV portfolio includes: Sabal, a heavy-lift logistics drone family (10–70 kg payloads) already inducted by the Indian Army’s Eastern Command; Vibhram, a long-endurance UAV that powered Telangana’s Medicine from the Sky vaccine delivery program; and Alakh, a nano-UAV series deployed in critical rescue missions from Chamoli cloudburst to the Turkey earthquake. It is also co-developing high-altitude logistics drones with Bharat Electronics Limited (BEL) and piloting missions in Bhutan with Druk Holding & Investments (DHI). The Noida-based startup competes with players like IdeaForge, Garuda Aerospace, and NewSpace Research.

Download the medial app to read full posts, comements and news.